Related Experiment Video

Updated: Jul 2, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

An Ovarian Cancer Tumor Marker, CA 125, Comes of Age

R E Buller, P J Disaia

    The Western Journal of Medicine
    |April 1, 1990
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
    10:58

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

    Published on: July 18, 2016

    An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
    10:35

    An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

    Published on: November 28, 2010

    Related Experiment Videos

    Last Updated: Jul 2, 2026

    An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
    05:42

    An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

    Published on: January 26, 2024

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
    10:58

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

    Published on: July 18, 2016

    An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
    10:35

    An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

    Published on: November 28, 2010

    Related Concept Videos

    Oogenesis02:07

    Oogenesis

    In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

    Articles linked to this work by shared authors, journal, and citation graph.

    SSCP and Sequence Analysis of p53 Mutations in Ovarian Tumors.

    Methods in molecular medicine·2011

    BRCA2 alteration is important in clear cell carcinoma of the ovary.

    Clinical genetics·2009

    Tunneled central venous catheters in a gynecologic oncology service: operative and short-term complications.

    European journal of gynaecological oncology·2008

    Asymptomatic lung carcinoma presenting with a large vulvar lesion.

    Journal of lower genital tract disease·2006

    E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.

    Oncogene·2006

    CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006

    Analysis of questions asked by family physicians regarding patient care.

    The Western journal of medicine·2008

    Gut microbiome-related plasma metabolites and risk of colorectal cancer.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

    Real-world screening for metabolic dysfunction-associated steatotic liver disease among adults with type 2 diabetes.

    Proceedings (Baylor University. Medical Center)·2026

    Identification of prediagnostic proteomic biomarkers for colon and rectal cancer in 3 prospective cohorts.

    Journal of the National Cancer Institute·2026

    Progress in the Mechanism of Heat Shock Proteins in Gastric Cancer: From Biomarkers to Therapeutic Targets.

    Immunity, inflammation and disease·2026

    H3K4me1-Mediated Epigenomic Priming of Chemoresistant Tumor States in Ovarian Cancer.

    Cancer discovery·2026

    Advances in Biomarkers and Novel Therapeutics in Renal Cell Carcinoma: Evidence from Recent Clinical Trials.

    Reviews on recent clinical trials·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us